FACC AG/ AT00000FACC2 /
| 2023-11-03 11:39:46 AM | Chg. - | Volume | Bid9:06:35 AM | Ask12:03:16 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 6.18EUR | - | 201 Turnover: 1,241.18 |
-Bid Size: - | -Ask Size: - | 284.36 mill.EUR | - | 31.05 |
GlobeNewswire
04-08
Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage R...
GlobeNewswire
04-07
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (...
GlobeNewswire
04-01
Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and Eu...
GlobeNewswire
03-27
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Dr...
GlobeNewswire
03-25
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & ...
GlobeNewswire
03-25
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
GlobeNewswire
03-13
Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Cent...
GlobeNewswire
03-12
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journa...
GlobeNewswire
02-27
Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients wit...
GlobeNewswire
02-20
Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Hear...
GlobeNewswire
02-07
Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomat...
GlobeNewswire
01-29
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Inve...
GlobeNewswire
01-23
The International Myeloma Foundation Mourns the Passing of IMF Board Member Dr. Edith Mitchell
GlobeNewswire
2023-12-27
Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammato...
GlobeNewswire
2023-12-20
Renexxion Ireland has Completed a Successful Pre-IND Consultation with the United States FDA for Dev...
GlobeNewswire
2023-12-12
MyCardiologist Revolutionizes Heart Health Assessment & Cardiac Event Reduction with Cutting-Edge Ca...
GlobeNewswire
2023-12-05
MedBright AI Announces Election of Two US Healthcare Experts to Board of Directors and Approval of N...
GlobeNewswire
2023-11-30
Renexxion Ireland Announces Issuance of Two U.S. Patents Covering a Novel Crystal Isoform of Naronap...
GlobeNewswire
2023-11-27
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglut...
GlobeNewswire
2023-11-13
Esperion Presents CLEAR Outcomes Analysis of Inflammation as Predictor of Cardiovascular Risk at Ame...
GlobeNewswire
2023-11-11
Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American...
GlobeNewswire
2023-11-08
Lexicon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
